http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100473658-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12R2001-865 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-81 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-185 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-19 |
| filingDate | 2002-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2005-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2005-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100473658-B1 |
| titleOfInvention | Transformed yeast system for developing therapeutic hybrid protein drug by site-specific modification |
| abstract | The present invention relates to a method for expressing a protein containing only N-acetylglucosamine using a transgenic yeast system in order to confer regioselectivity in modification of proteins for therapeutic, research and industrial purposes. More specifically, by using a transformed yeast strain from which the genes related to sugar chains have been removed, a sugar chain addition reaction is induced in the form of having only en-acetylglucosamine instead of the existing oligosaccharide, thereby forming a functional chain of amino acids constituting the protein chain. Is to provide a transgenic yeast system for producing glycoproteins in a form in which only en-acetylglucosamine having distinct functional groups is added to the existing sugar chain portion. |
| priorityDate | 2002-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 476.